Winvild-M Tablet

The synergistic action of these agents helps in achieving better control of fasting and postprandial blood glucose levels. Winvild-M is typically prescribed when diet, exercise, and monotherapy with either agent do not provide adequate glycemic control. It is important to monitor renal function prior to and during therapy, as Metformin is contraindicated in patients with significant renal impairment due to the risk of lactic acidosis.

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as headache and dizziness. Patients should be advised to adhere to prescribed dosages and report any adverse effects promptly. Winvild-M should be used as part of a comprehensive diabetes management plan including lifestyle modifications.